Back
Argan, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
AGX
Argan, Inc.
Last Price:
$314.00
Seasonality Move:
4.84%
Buy
75
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$113.31
Seasonality Move:
-9.01%
Buy
64
Argan, Inc. (AGX)
is a Buy
Is Argan, Inc. a Buy, Sell or Hold?
-
The current Argan, Inc. [AGX] share price is $330.60. The Score for AGX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $117.62. The Score for RYTM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AGX Stock Price Chart
What is Argan, Inc.'s stock price today?
-
The Argan, Inc. share price today is $330.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGX is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $117.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
AGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.99 | Buy |
| Relative Strength Index (14 RSI): | 48.28 | Sell |
| Chaikin Money Flow: | 37834 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (325.29 - 368.19) | Sell |
| Bollinger Bands (100): | (227.49 - 325.91) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 65.29 | Buy |
| Chaikin Money Flow: | 622990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.54 - 107.68) | Buy |
| Bollinger Bands (100): | (93.66 - 107.58) | Buy |
AGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 335.9 | Sell |
| 20-day SMA: | 349.84 | Sell |
| 50-day SMA: | 317.29 | Buy |
| 200-day SMA: | 223.95 | Buy |
| 8-day EMA: | 336.11 | Sell |
| 20-day EMA: | 339.96 | Sell |
| 50-day EMA: | 318.86 | Buy |
| 200-day EMA: | 241.02 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.58 | Buy |
| 20-day SMA: | 104.18 | Buy |
| 50-day SMA: | 104.81 | Buy |
| 200-day SMA: | 81.44 | Buy |
| 8-day EMA: | 107.12 | Buy |
| 20-day EMA: | 105.38 | Buy |
| 50-day EMA: | 103.54 | Buy |
| 200-day EMA: | 86.38 | Buy |
Argan, Inc. Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.14 per share, an increase this year of $2.73 per share, and an increase next year of $3.30 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Argan, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||